Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Autoimmune Diseases, CNS

Explore clinical trials studying Demyelinating Autoimmune Diseases, CNS. Study availability and eligibility vary by location and protocol.

2,726 public trials 402 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Autoimmune Diseases, CNS trial results

Recruiting

High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Immune Cell Network

NCT06863974

Conditions
Acute Disseminated Encephalomyelitis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +14 more
Locations
  • CHU d'Angers Angers, France
  • Univesity Hostipal of Brest Brest, France
  • Univesity Hostipal of APHP Le Kremlin-Bicêtre, France
  • CHU Montpellier Montpellier, France
View Trial Details
Recruiting

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

NCT06312644

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +44 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site Melbourne, Victoria, Australia
  • Research Site Paris, France
  • Research Site Essen, Norte-Westfalia, Germany
View Trial Details
Recruiting

Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis

NCT06441617

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +7 more
Locations
  • Washington VA Medical Center Washington D.C., District of Columbia, United States
  • Baltimore VA Medical Center Baltimore, Maryland, United States
  • iConquerMS Waltham, Massachusetts, United States
  • Portland VA Medical Center Portland, Oregon, United States
View Trial Details

Related conditions